Identifying biomarkers of response and toxicity can help clinicians select the most safe and effective drugs for individual patients with rheumatoid arthritis. Personalized Medicine
A summary by Philip Mease, MD, of new developments for the management of psoriatic arthritis as illustrated by data presented at EULAR 2008. Medscape Rheumatology
This review summarizes the most recent data on the role of exercise, and nonpharmacologic therapies in ankylosing spondylitis. Current Opinion in Rheumatology
Physical activity levels are low in adolescents with juvenile idiopathic arthritis (JIA), and this appears to be unrelated to disease activity, study findings in the October 15th issue of Arthritis and Rheumatism indicate. Reuters Health Information
Update on treatments for juvenile idiopathic arthritis, as illustrated by data from the American College of Rheumatology 2007 scientific meeting. Medscape Rheumatology
Might multiplex antinuclear antibody assay be reliable enough to replace immunofluorescence assay as a screening method for evaluation of rheumatologic disorders in children less than 16 years of age? Laboratory Medicine
